Table 3 from Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接:
官方服务:
资源简介:
PK parameters of TTI-101 in plasma.
创建时间:
2025-03-17

PK parameters of TTI-101 in plasma.